Abdel Gaffar Mohammed/X
Sep 7, 2026, 23:56
Abdel Gaffar Mohammed: Treatment Approaches for Different Types of TMA
Abdel Gaffar Mohammed, IM/Rheumatology consultant at KAH, shared a post on X:
“TMA Treatment Lupus-TTP and APS-TMA are treated with combinations of plasma exchange, high-dose glucocorticoids, rituximab, and anticoagulation.
Complement-mediated TMA relies on targeted complement inhibition (eculizumab or ravulizumab) as the cornerstone of therapy.”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 03:54Jennifer Trowbridge: How Mutant Blood Stem Cells Use Inflammation to Drive Their Own Expansion
-
Oct 19, 2026, 03:39Wyenona Hicks: Catching Up With Old Friends and New Colleagues at AABB 2026
-
Oct 19, 2026, 03:33Developing a Non-Invasive Treatment for Life-Threatening PE – University of Michigan College of Engineering
-
Oct 19, 2026, 03:28Jim Hoffman: How NETs Contribute to Gallstone Formation and Growth
-
Oct 19, 2026, 03:28Nicolas Hubacz: The Organized Chaos of Mitochondria
-
Oct 19, 2026, 03:02Neda Horvacki: Using ROTEM to Refine Transfusion Decisions in Acute Trauma
-
Oct 19, 2026, 02:45Diego Escarraman Martinez: MATTERs Study – When a Cohort Gave Us Major Clues about TXA in Trauma
-
Oct 19, 2026, 02:35Brian O Mahony: Promoting Physical Activity and Sport in Haemophilia Care
-
Oct 19, 2026, 02:35Malusi Mtetwa: Tranexamic Acid – What Does the Evidence Tell Us?